33
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Carbohydrate 19-9 Antigen as a Marker of Non-Malignant Hepatocytic Ductular Transformation in Patients with Acute Liver Failure: A Comparison with Alpha-Fetoprotein and Carcinoembryonic Antigen

Pages 426-431 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eric I Marks, Matthew Brennan & Wafik S El-Deiry. (2015) Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma. Cancer Biology & Therapy 16:8, pages 1136-1139.
Read now

Articles from other publishers (10)

Jie Zhang, Shang Dong Qin, Yan Li, Fei Lu, Wen Feng Gong, Jian Hong Zhong, Liang Ma, Jing Fei Zhao, Guo Hua Zhan, Peng Zhan Li, Bin Song & Bang De Xiang. (2022) Prognostic significance of combined α-fetoprotein and CA19-9 for hepatocellular carcinoma after hepatectomy. World Journal of Surgical Oncology 20:1.
Crossref
Adrianne Tsen, Mary Barbara & Laura Rosenkranz. (2018) Dilemma of elevated CA 19-9 in biliary pathology. Pancreatology 18:8, pages 862-867.
Crossref
Jiajia Dong, Yijing Cai, Ruicong Chen, Shanjie Du, Yongping Chen & Keqing Shi. (2015) A Case Report and a Short Literature Review of Pulmonary Sequestration Showing Elevated Serum Levels of Carbohydrate Antigen 19-9. Journal of Nippon Medical School 82:4, pages 211-215.
Crossref
M. Ventrucci, P. Pozzato, A. Cipolla & G. Uomo. (2009) Persistent elevation of serum CA 19-9 with no evidence of malignant disease. Digestive and Liver Disease 41:5, pages 357-363.
Crossref
Neal S. Goldstein & David S. Bosler. 2006. Diagnostic Immunohistochemistry. Diagnostic Immunohistochemistry 442 508 .
Paul T Jubinsky, James Pullman, Netta Blitman & Melissa Tesher. (2005) Abdominal Pain in a Patient With Osteosarcoma. Journal of Pediatric Hematology/Oncology 27:12, pages 678-680.
Crossref
M. Montalto, L. Santoro, M. Vastola, V. Curigliano, R. Ricci, F.M. Vecchio, R. Manna & G. Gasbarrini. (2016) Normalisation of High Ca 19-9 Values in Autoimmune Hepatitis after Steroidal Treatment. International Journal of Immunopathology and Pharmacology 18:3, pages 603-607.
Crossref
Nora Bettinardi, Irene Felicetta, Paolo A. Tomasi & Carla Colombo. (2003) Carbohydrate 19-9 Antigen Is Not a Marker of Liver Disease in Patients with Cystic Fibrosis. Clinical Chemistry and Laboratory Medicine 41:3.
Crossref
Y Kitagawa, M Iwai, A Muramatsu, S Tanaka, T Mori, Y Harada, T Okanoue & K Kashima. (2002) Immunohistochemical localization of CEA, CA19-9 and DU-PAN-2 in hepatitis C virus-infected liver tissues. Histopathology 40:5, pages 472-479.
Crossref
E. GianniniP. BorroF. BottaB. ChiarbonelloA. FasoliF. MalfattiP. RomagnoliE. TestaD. Risso, P.B. Lantieri, A. Antonucci, M. Boccato, S. Milone & R. Testa. (2018) Cholestasis is the Main Determinant of Abnormal CA 19–9 Levels in Patients with Liver Cirrhosis. The International Journal of Biological Markers 15:3, pages 226-230.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.